Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation

v3.24.1.u1
Share-Based Compensation
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
The following tables summarize the activity during the period under the Company's 2014 Amended and Restated Stock Incentive Plan (the "2014 Plan") and 2021 Equity Incentive Plan (the "2021 Plan").
Restricted Stock Awards
Number of
shares
Weighted
average
grant
date fair
value
Unvested at December 31, 2023 529,862  $ 11.42 
Granted 88,499  9.09 
Vested (67,844) 17.44 
Vested shares forgone to satisfy minimum statutory withholding (38,656) 17.44 
Forfeitures (3,500) 13.25 
Unvested at March 31, 2024 508,361  $ 9.74 
Three Months Ended March 31,
2024 2023
0
Weighted average grant date fair value of awards granted $ 9.09  $ — 
Total fair value of shares vested $ 641,823  $ 273,994 
Total fair value of shares forgone to satisfy minimum statutory withholding $ 365,697  $ 167,251 
Performance-Based Restricted Stock Units ("PSU")
For the three months ended March 31, 2024, there were no grants, vesting, or forfeitures of PSUs.
Stock Options
2014 Plan (Options) Number
of Authorized
Shares
Weighted-
Average Exercise
Price
Weighted-
Average
Remaining
Contractual Term (in Years)
Aggregate
Intrinsic Value
Outstanding at December 31, 2023 657,346  $ 6.69  4.16 $ 2,983,514 
Forfeitures and expirations (500) 18.44 
Outstanding at March 31, 2024 656,846  $ 6.68  3.91 $ 2,099,944 
Exercisable at March 31, 2024 656,846  $ 6.68  3.91 $ 2,099,944 
Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.
2021 Plan (Options) Number
of Authorized
Shares
Weighted-
Average Exercise
Price
Weighted-
Average
Remaining
Contractual Term (in Years)
Aggregate
Intrinsic Value
Outstanding at December 31, 2023 1,051,673  $ 11.05  8.79 $ 1,207,118 
Granted 152,927  8.97 
Forfeitures and expirations (31,291) 9.73 
Outstanding at March 31, 2024 (a) 1,173,309  $ 10.81  8.71 $ — 
Exercisable at March 31, 2024 (a) 309,597  $ 14.31  7.60 $ — 
(a) Aggregate Intrinsic Value - no exercisable options were in-the-money as of March 31, 2024
Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.

The following is the average fair value per share estimated on the date of grant and the assumptions used for options granted:
Three Months Ended March 31,
Stock Options: 2024
Expected volatility
50% to 51%
Risk free interest rate
4.25% to 4.28%
Expected lives at date of grant (in years) 4.06
Weighted average fair value of options granted $3.97
Total intrinsic value of options exercised $ — 
For the three months ended March 31, 2023, the Company did not grant any options, and thus that time period is excluded from the table above.